These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4383224)

  • 21. [Antipsychotic neuroplegic and neuroleptic agents. III. Phenothiazines (2nd part)].
    Deligné P; Bunodière M
    Ann Anesthesiol Fr; 1978; 19(8):1I-13I. PubMed ID: 31109
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
    Cashin CH; Sutton S
    Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
    Hubbard CA; Trugman JM
    Mov Disord; 1993 Oct; 8(4):473-8. PubMed ID: 7901761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arousal inhibiting and catalepsy in neuroleptic drugs].
    Stille G
    Arzneimittelforschung; 1966 Feb; 16(2):255-6. PubMed ID: 6013811
    [No Abstract]   [Full Text] [Related]  

  • 25. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [2-chlor-4-azaphenthiazine. Synthesis and pharmacological properties of cloxypendyl].
    Gross A; Thiele K; Schuler WA; von Schlichtegroll A
    Arzneimittelforschung; 1968 Apr; 18(4):435-42. PubMed ID: 4387157
    [No Abstract]   [Full Text] [Related]  

  • 27. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on central nervous system depressants. (II). The action of some general nervous depressants on coaxically stimulated guineapig's ileum.
    DANDIYA PC
    Arch Int Pharmacodyn Ther; 1963 Jan; 141():216-22. PubMed ID: 14024877
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat.
    Banjaw MY; Mayerhofer A; Schmidt WJ
    Synapse; 2003 Sep; 49(4):232-8. PubMed ID: 12827642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the pharmacology of the active substances of betel. 1. Central effect of arecoline].
    Nieschulz O
    Arzneimittelforschung; 1967 Oct; 17(10):1292-7. PubMed ID: 5632880
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the mechanism of postetorphine catalepsy. Effects of clotiapine, haloperidol and rompun on postetorphine changes in concentrations of dopamine and noradrenaline in central nervous system of rats.
    Kania BF
    Acta Physiol Pol; 1980; 31(1):9-16. PubMed ID: 6103632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of new tropine ethers with central activity.
    György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
    Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
    [No Abstract]   [Full Text] [Related]  

  • 34. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
    Zharkovskiĭ AM; Riago LK; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of 3-indolylacetylaminorhodanine on the central nervous system of albino rats].
    Nevelichuk VV
    Farmakol Toksikol; 1967; 30(4):401-2. PubMed ID: 5598886
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.
    Bizière K; Kan JP; Souilhac J; Muyard JP; Roncucci R
    Arzneimittelforschung; 1982; 32(8):824-31. PubMed ID: 6890359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
    Mikhaĭlova TV; Terekhina AI; Gilev AP
    Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
    [No Abstract]   [Full Text] [Related]  

  • 39. Central action of narcotic analgesics. IX. Participation of serotonin in the development of tolerance to cataleptogenic effects of morphine in rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):437-44. PubMed ID: 6460229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventive effect of massive doses of thiamine in the chlorpromazine-induced neuroleptic syndrome].
    NEVEU P; L'HERMIT M; RUYER M
    Ann Med Psychol (Paris); 1958 Jul; 116 Vol 2(2):330-3. PubMed ID: 13571684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.